Study: Antioxidant Supplementation Not Associated With Decreased Risk of Prostate Cancer
Intakes of dietary or supplemental antioxidants were not associated with a decreased risk of prostate cancer among men in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Study: Obesity Independently Impacts Prostate Cancer Screening
When interpreting prostate cancer screening test results, physicians should consider the impact of a patient's body mass index, regardless of race.
Researchers Discover Blood Stem Cells
New discovery marks an important step in the quest to master diabetes, cancer, heart disease, sight-robbing retinal disorders and a multitude of other medical conditions.
Diabetes Increases Risk of Developing and Dying from Breast and Colon Cancer
Researchers have found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
New Diet-Cancer Research Shows Variety to be Key to Cancer Prevention
Researchers studying the diet-cancer link are devoting a new level of scientific attention to a dietary factor that many people take for granted - variety.
Drugs Commonly Used for Erectile Dysfunction Allowed More Chemotherapy to Reach Brain Tumors
Researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.
Study Suggests Women May Need More Vitamin C
Recent findings by researchers at NIDDK and Vanderbilt University indicate that the RDA of vitamin C may need to increase to 90 milligrams a day for young women.
Mayo Clinic Researchers Report Diabetic Women Less Likely to Undergo Mammograms
Mayo Clinic researchers have found that women with diabetes were significantly less likely to undergo screening for breast cancer by mammography than patients in a control group.
Could Diabetes Treatments Fight Cancer?
Drugs that treat diabetes may also be effective against some cancers.
FDA Approves New Treatment for Gastrointestinal and Kidney Cancer
FDA announced approval of Sutent, a new targeted anti-cancer treatment for patients with gastrointestinal stromal tumors, a rare stomach cancer, and advanced kidney cancer.
Diabetes Drug Shows Promise in Reducing Risk of Cancer
An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study.
Diabetes, Heart Disease Can Herald Early GI Cancers
Heart disease and diabetes are among the most common conditions plaguing Americans today, and they are related to a host of other diseases. Research now also demonstrates that these conditions can be warning signs for some types of digestive cancers.
New Company Will Seek Drugs Against Diabetes and Cancer
A new company will use a novel technology to rapidly screen thousands of drugs for their effectiveness against two of the biggest health threats in the United States, diabetes and cancer.
Metabolic Syndrome Ups Colorectal Cancer Risk
In a large U.S. population-based study, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.
Link Between Diabetes Drug Actos (Pioglitazone) and Bladder Cancer Risk Scrutinized
Researchers analyzed 200,000 patients to examine the suspected link between pioglitazone (Actos), which is used to treat diabetes, and an increased risk of bladder...
Study: Saw Palmetto No Better Than Placebo For Enlarged Prostate
Saw palmetto, an herbal extract commonly taken to improve urinary symptoms in men with enlargement of the prostate gland, is no more effective than a placebo.
